<DOC>
	<DOCNO>NCT01198821</DOCNO>
	<brief_summary>The purpose study : Find large dose sodium bicarbonate give gemcitabine . Determine combination sodium bicarbonate gemcitabine produce good control pancreatic cancer gemcitabine alone .</brief_summary>
	<brief_title>Gem-TABS Unresectable Pancreatic Carcinoma</brief_title>
	<detailed_description>Gemcitabine administer intravenous drip 30 minute dose 1000 mg/m2 day 1 , 8 , 15 cycle follow 7-day treatment rest period . No treatment administer 4th week cycle . Each cycle 28 day long . Sodium bicarbonate commercially available supply tablet water soluble powder . It stable solid form need refrigeration . The sodium bicarbonate dispense pharmacy packet contain 1/3 daily dose . The patient ask dissolve powder water 3 time per day consume dose period 30 minute . Patients require refrain use additional buffering agent ( antacid ) include sodium bicarbonate , CaCO3 , aluminum hydroxide .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<criteria>Patients must histologically confirm pancreatic adenocarcinoma metastatic unresectable . Patients previously untreated chemotherapy metastatic setting . Prior 5FU capecitabine treatment allow : 1 ) give part combine modality chemoradiation regimen adjuvant set ; 2 ) great 30 % bone marrow include field ; 3 ) treatment free interval ≥ 6 week . Patients must measurable disease , define least one lesion measure least one dimension ( long diameter record ) ≥ 20 mm conventional technique ≥ 10 mm spiral CT scan . ECOG performance status ≤2 ( Karnofsky ≥60 % ) . Patients must normal organ marrow function define : leukocyte ≥ 3,000/μl absolute neutrophil count ≥ 1,500/μl platelet ≥ 100,000/μl total bilirubin ≤2.5 X institutional upper limit normal AST ( SGOT ) /ALT ( SGPT ) ≤2.5 X institutional upper limit normal AST ( SGOT ) /ALT ( SGPT ) ≤5 X institutional upper limit normal patient liver metastasis creatinine ≤1.5 X institutional upper limit normal creatinine clearance &gt; 30 ml/min ( CockcroftGault method ) Has negative serum urine pregnancy test within 7 day prior initiation therapy ( female patient childbearing potential ) . Postmenopausal woman must amenorrheic least 12 month consider nonchildbearing potential . Patients agree continue contraception 30 day date last study drug administration . Ability understand willingness sign write informed consent document . Patients prior chemotherapy pancreatic adenocarcinoma metastatic setting Patients receive chemoradiation within last 6 week prior registration Patients know allergy severe reaction gemcitabine Patients uncontrolled hypertension history uncontrolled congestive heart failure Patients may receive investigational agent receive investigational agent within 28 day prior registration . Patients know brain metastasis exclude . Patients active ( remission ) malignancies pancreatic cancer Pregnant woman exclude study gemcitabine Class D agent potential teratogenic abortifacient effect . Patients immune deficiency increase risk lethal infection treat marrowsuppressive therapy . Therefore , HIVpositive patient receive combination antiretroviral therapy exclude study . Patients require ongoing ( chronic ) treatment medication , absorption may alter NaHCO3 ( benzodiazepine , flecainide , ketoconazole , lithium , iron salt , methenamine , methotrexate , quinidine , sulfacontaining antibiotic , tetracycline ) , switch alternate medication exclude . Patients routinely use antacid include sodium bicarbonate , aluminum hydroxide , calcium carbonate exclude . Patients document history severe* COPD exclude . *defined GOLD stage III great . For patient documented history COPD , pulmonary function test establish GOLD stage must document within 6 week prior start protocol therapy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>pancreas</keyword>
	<keyword>adenocarcinoma</keyword>
	<keyword>metastatic</keyword>
	<keyword>unresectable</keyword>
</DOC>